These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 15220671

  • 1. Probiotics in the treatment of irritable bowel syndrome.
    Saggioro A.
    J Clin Gastroenterol; 2004 Jul; 38(6 Suppl):S104-6. PubMed ID: 15220671
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis.
    Ortiz-Lucas M, Tobías A, Saz P, Sebastián JJ.
    Rev Esp Enferm Dig; 2013 Jan; 105(1):19-36. PubMed ID: 23548007
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
    Bixquert Jiménez M.
    Rev Esp Enferm Dig; 2009 Aug; 101(8):553-64. PubMed ID: 19785495
    [Abstract] [Full Text] [Related]

  • 6. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
    Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R.
    Scand J Gastroenterol; 2011 Jun; 46(6):663-72. PubMed ID: 21443416
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
    Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE.
    Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590
    [Abstract] [Full Text] [Related]

  • 11. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
    Leventogiannis K, Gkolfakis P, Spithakis G, Tsatali A, Pistiki A, Sioulas A, Giamarellos-Bourboulis EJ, Triantafyllou K.
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):627-634. PubMed ID: 29508268
    [Abstract] [Full Text] [Related]

  • 12. The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study.
    Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kosikowski W, Szczerbiński M, Gantzel J, Cukrowska B.
    Nutrients; 2020 Jul 05; 12(7):. PubMed ID: 32635661
    [Abstract] [Full Text] [Related]

  • 13. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
    Sadrin S, Sennoune SR, Gout B, Marque S, Moreau J, Grillasca J, Pons O, Maixent JM.
    Cell Mol Biol (Noisy-le-grand); 2017 Sep 30; 63(9):122-131. PubMed ID: 28980935
    [Abstract] [Full Text] [Related]

  • 14. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
    Andresen V, Gschossmann J, Layer P.
    Lancet Gastroenterol Hepatol; 2020 Jul 30; 5(7):658-666. PubMed ID: 32277872
    [Abstract] [Full Text] [Related]

  • 15. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG.
    J Gastroenterol Hepatol; 2014 Jan 30; 29(1):52-9. PubMed ID: 23829297
    [Abstract] [Full Text] [Related]

  • 16. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.
    O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM.
    Gastroenterology; 2005 Mar 30; 128(3):541-51. PubMed ID: 15765388
    [Abstract] [Full Text] [Related]

  • 17. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome.
    Stevenson C, Blaauw R, Fredericks E, Visser J, Roux S.
    Nutrition; 2014 Oct 30; 30(10):1151-7. PubMed ID: 25194614
    [Abstract] [Full Text] [Related]

  • 18. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
    Camilleri M.
    J Clin Gastroenterol; 2008 Sep 30; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
    [Abstract] [Full Text] [Related]

  • 19. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
    Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L.
    World J Gastroenterol; 2016 Dec 28; 22(48):10631-10642. PubMed ID: 28082816
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
    Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM.
    Am J Gastroenterol; 2006 Jul 28; 101(7):1581-90. PubMed ID: 16863564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.